Pharmaceutical Management Agency

Rationale for defunding of Androderm 2.5mg Patches

Response by Pharmaceutical Management Agency to Scout Barbour-Evans on June 11, 2019.

Successful.

Hello Scout Androderm 2.5mg patches were delisted from the Pharmaceutical Schedule from 1 March 2018. In October 2016, the manufacturers proposed del...

Consumer Advisory Committee (CAC)

Response by Pharmaceutical Management Agency to john luke on April 23, 2020.

Successful.

Good afternoon John Please find attached PHARMAC's response to your recent request for information about CAC membership. Kind regards, Susan Susan...

Shortage of Phenelzine sulphate

Response by Pharmaceutical Management Agency to Megs on October 14, 2019.

Successful.

Dear Megs Please find attached a letter and related documents related to your request for information about phenelzine supply. Kind regards Simon E...

Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine

Response by Pharmaceutical Management Agency to Belinda Hodson on April 07, 2020.

Awaiting classification.

Good morning Belinda Please find attached PHARMAC's response to your recent request for information about the funding of Whole Thyroid Extract and Lio...

Citation list for PHARMAC funded thyroid medications and patient survey data

Response by Pharmaceutical Management Agency to Belinda Hodson on February 24, 2020.

Partially successful.

Dear Belinda Please find attached further correspondence in relation to your request for information about thyroid medications (OIA reference 2019-20-...

Approval of PHARMAC funded thyroid medications

Response by Pharmaceutical Management Agency to Belinda Hodson on January 24, 2020.

Partially successful.

Good afternoon Belinda. Please find attached our response to your request for PTAC minutes and the Endocrinology Subcommittee minutes that recommended...

PrEP Correspondence

Response by Pharmaceutical Management Agency to Gemma Crawley on October 08, 2019.

Information not held.

Dear Gemma Please find attached a response to your request for information about PREP correspondence Kind regards Simon England | Se...

Pharmac Funding Applications

Response by Pharmaceutical Management Agency to Gemma Crawley on July 31, 2019.

Successful.

Hi Gemma Most of the funding applications we receive come from suppliers. NZAF did apply to us for PrEP. And the Breast Cancer Aotearoa Coalition appl...

PrEP

Response by Pharmaceutical Management Agency to Gemma Crawley on June 04, 2019.

Partially successful.

Hi Gemma apologies the wrong link, Vikki https://www.pharmac.govt.nz/news/notification-2018-02-07-prep/

Vanlafaxine - Bioavailability studies

Response by Pharmaceutical Management Agency to R Whyte on June 13, 2019.

Awaiting classification.

Dear Mt Whyte Please find attached a response to you and the information requested. Kind regards Donna Jennings PHARMAC 10 Jun...

Consumer Advisory Committee

Response by Pharmaceutical Management Agency to john luke on May 30, 2019.

Successful.

Hello John I am replying on behalf of Katie. The member's term of appointment is for up to three years. You can express an interest by contacting [e...

List of most most costly and most prescribed medications

Response by Pharmaceutical Management Agency to Sam Wagener on January 23, 2019.

Refused.

Dear Mr Wagener Please find attached a letter regarding your request for official information. Yours sincerely Ministerial Support Services [em...

Arrow Venlafaxine needs to come back under NZ funding.

Response by Pharmaceutical Management Agency to VICKI CAREY on September 25, 2018.

Partially successful.

Kia ora Vicki Thank you for your enquiry. You have asked why the Arrow-Venlafaxine XR and Efexor XR brands were removed when it was doing good f...

Arrow Venlafaxine

Response by Pharmaceutical Management Agency to Trudi Webber on August 02, 2018.

Successful.

Dear Trudi Thank you for your query regarding the initial listing date for Arrow-Venlafaxine XR tablets in the Pharmaceutical Schedule. Ar...

Who did the research that was used to compare Enlafax with other brands?

Response by Pharmaceutical Management Agency to Trudi Webber on May 24, 2018.

Successful.

Dear Ms Webber, Kindly note the Ministry is awaiting your clarification please on your request. Kind regards Maima Ministerial Services (OIA) [...

dexrazoxane NPPA Approval

Response by Pharmaceutical Management Agency to Ian Kennedy on June 07, 2018.

Awaiting classification.

Dear Ian This email is to acknowledge that your request for information under the Official Information Act (1982) has been received and is curre...

Dispensed drugs, media and events information request

Response by Pharmaceutical Management Agency to Joe Heihei on May 25, 2018.

Awaiting classification.

Dear Joe Please see attached the response to your OIA request. Kind regards Dean Zeng PHARMAC 25 May 2018 Dear Joe REQUEST FO...

Cost of Effexor v's Enlafax

Response by Pharmaceutical Management Agency to Sarah Bellamy on May 14, 2018.

Awaiting classification.

Hi Sarah As stated in my previous response, you can find information about the number of people on venlafaxine in our Year in Review 2017 document: ht...

Clarification of Pharmaceutical Schedule from Prior Request

Request to Pharmaceutical Management Agency by Amanda Ashley. Annotated by Amanda Ashley on February 13, 2018.

Successful.

1) Googling "NZ Guidelines Group" The New Zealand Guidelines Group (NZGG) was an independent, not-for-profit organisation, set up in 1999 to promote...

Request for list of HRT pharmaceuticals available in NZ and their funding status

Request to Pharmaceutical Management Agency by Amanda Ashley. Annotated by Amanda Ashley on February 13, 2018.

Partially successful.

Following on from my post about the reply I got from PHARMAC I have compiled a document with all of the relevant information and available pharmaceutic...

Cost of HPV vaccine

Response by Pharmaceutical Management Agency to Virginia Crawford on August 03, 2017.

Successful.

Dear Virginia Please find attached a response to your request. Kind regards Donna Donna Jennings | Communications Advisor 3 August 2017 Via email:...

Management of Stelazine (trifluoperazine) supply

Response by Pharmaceutical Management Agency to WGRH on January 31, 2017.

Information not held.

Dear Dr Harrison, Please find PHARMAC's response to your OIA request attached. Please let me know if you have any questions on this. Kind Regards,...

Request Regarding the top dispensed drugs/most expensive drugs for 2016

Response by Pharmaceutical Management Agency to Sam Wagener on February 24, 2017.

Successful.

Hi Sam Please find attached a response to your OIA request. Kind regards Donna Jennings PHARMAC 24 February 2016 Via email: [email address]> Dear Sam...

Which thyroid medications and bio-identical T4, T3 equivalents meet criteria for government funding

Response by Pharmaceutical Management Agency to Belinda Hodson on September 18, 2015.

Successful.

Hi, Would you be interested to procure an opt-in email list of Medical Equipment Manufacturing Professionals which includes complete verified c...

NPPA Requests, Intrathecal baclofen

Response by Pharmaceutical Management Agency to Shane Le Brun on July 05, 2016.

Successful.

Dear Shane Please find attached, PHARMAC's response to your recent OIA request. Kind regards Victoria London | Communications Adviser 5 July 2016...

FYI

(page 3)

More about this authority